Request FREE sample PDF
Pharmacy benefit management market
Tylosin Market Report Overview
The global tylosin market size was valued at USD 689.4 million in 2021. Based on our analysis, the market is projected to reach USD 1043 million by 2031, registering a CAGR of 4.2% during the forecast period.
Tylosin is an antibiotic drug used to treat bacterial infections in animals. It is primarily used in poultry, swine, and cattle to prevent and treat respiratory infections, diarrhea, and other diseases. Tylosin is available in different forms such as injectable, powders, and premixes. Tylosin shares structural similarities with the macrolide antibiotic erythromycin, which is used in both humans and animals.
Streptococcus pneumoniae, S. pyogenes, Staphylococcus aureus, as well as several other organisms including Legionella pneumonia, Chlamydophila pneumoniae, and Mycoplasma pneumonia, can all cause infections in humans that can be treated with macrolides. In the livestock business, antimicrobial drugs are typically used to treat a variety of illnesses in livestock, prevent disease, and enhance the growth rate of the animals. Additionally, it has been discovered that antimicrobial drugs work well in animals to increase weight and growth rates more quickly, which increases meat producers' profits.
COVID-19 Impact- supply chain disruption depleted market growth during the lockdown
The COVID-19 pandemic has had a mixed impact on the global tylosin market. The pandemic led to disruptions in the global supply chain, affecting the production and distribution of the product. However, the increasing demand for animal-based products during the pandemic and the growing awareness about animal health and welfare have led to a surge in the demand for the drug in the animal feed industry.
Latest Trends
"Adoption of advanced production technologies to bolster market growth"
The global tylosin market is witnessing some latest trends, including the adoption of advanced production technologies, the development of new formulations, and the increasing focus on research and development activities. Moreover, the growing trend of using antibiotics in combination with other drugs to enhance their efficacy is also expected to drive the demand for the drug in the animal healthcare industry.
Tylosin Market Segmentation
- By Type Analysis
Based on type, the market can be segmented into tylosin tartrate, tylosin phosphate, and others.
- By Application Analysis
Based on application, the market can be segmented into animal feed additives, animal drugs, and others.
Driving Factors
"Increasing Demand for Animal-Based Products to elevate market growth"
The increasing demand for animal-based products such as meat, milk, and eggs is expected to drive the demand for the product in the animal feed industry. Tylosin is primarily used to prevent and treat bacterial infections in animals, which helps improve their health and productivity.
"Rising Prevalence of Bacterial Infections in Livestock to augment the product demand"
The rising prevalence of bacterial infections in livestock is expected to drive the demand for tylosin in the animal healthcare industry. Tylosin is an effective antibiotic drug used to treat respiratory infections, diarrhea, and other diseases in animals.
"Advancements in Production Technologies to cater lucrative growth opportunities"
The availability of advanced production technologies such as fermentation and synthesis is expected to boost the production of the product and improve its quality. The development of new formulations of tylosin is also expected to enhance its efficacy and expand its application in the animal healthcare industry.
Restraining Factors
"Strict Regulatory Guidelines may impede market growth"
The strict regulatory guidelines for the use of antibiotics in animal feed and healthcare are one of the significant factors restraining the tylosin market growth. The increasing concerns about antibiotic resistance and the potential health risks associated with the use of antibiotics in animals have led to stringent regulations and guidelines by regulatory authorities.
"Side Effects Associated with Tylosin to restrict market expansion"
The side effects associated with the use of tylosin, such as diarrhea, vomiting, and gastrointestinal disturbances, are another factor limiting the market growth. The increasing awareness about the potential health risks associated with the use of antibiotics in animals is also expected to hamper the market growth.
Tylosin Market Regional Insights
"North America to lead the market due to the rising demand for animal protein in the region"
North America is expected to lead the global tylosin market due to the increasing demand for animal protein, the presence of established livestock industries, and the high adoption of veterinary antibiotics in the region.
Key Industry Players
"Key companies to adopt organic and inorganic strategies to grow in the global market"
The global Tylosin market is highly competitive, with key players adopting various strategies to maintain their market position. Many companies are investing in research and development to improve product quality and launch innovative products. Collaborative efforts through partnerships and mergers and acquisitions are also helping market players stay ahead of the competition.
List of market players profiled:
- Elanco (USA)
- Huvepharma (Bulgaria)
- Tairui (China)
- Lukang Shelile (China)
- Qilu Pharmaceutical (China)
- Top Pharm Chemical Group (China)
- HISUN (China)
- Apeloa (China)
Report Coverage
This report provides a comprehensive analysis of the global Tylosin Market, considering factors like segmentation, industrial developments, trends, opportunities, growth, size, share, and restraints. The report also profiles key industry players and offers a detailed analysis of their strategies, partnerships, and collaborations. The analysis is subject to alteration if the key players and probable analysis of tylosin market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 689.4 Million in 2021 |
Market Size Value By |
US$ 1043 Million by 2031 |
Growth Rate |
CAGR of 4.2% from 2021 to 2031 |
Forecast Period |
2022-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What is the expected value of the Global Tylosin Market?
The global tylosin market is expected to reach USD 922.6 million by 2031.
-
What is the expected CAGR of the Global Tylosin Market during 2022-2031?
The global tylosin market is expected to exhibit a CAGR of 4.2% over 2022-2031.
-
What are the driving factors of the Global Tylosin Market?
The increasing demand for animal protein, rising prevalence of bacterial infections in animals, and the need for effective treatments are the major driving factors for the Global Tylosin Market.
-
Which are the top companies operating in the Global Tylosin Market?
The major players operating in the Global Tylosin Market include Elanco, Huvepharma, Tairui, Lukang Shelile, Qilu Pharmaceutical, Top Pharm Chemical Group, HISUN, Apeloa, among others are the top companies operating in the Global Tylosin Market